Related by context. Frequent words. (Click for all words.) 67 confirmatory Phase III 67 PROPEL trial 66 BLA submission 63 confirmatory Phase 3 63 TOCOSOL Paclitaxel 63 Phase 2a trial 63 phase IIa 62 Phase 2b study 62 Board DSMB 61 L MTP PE 61 Zerenex 61 talactoferrin 61 Phase IIa clinical trials 61 Phase III pivotal 60 phase IIb 60 alvimopan 60 SILENOR TM 60 Phase 1b trial 60 PREOS 60 Phase 2b trial 60 axitinib 60 CoFactor 60 eniluracil 60 Phase 2b clinical 60 pralatrexate 59 Genasense R oblimersen 59 Phase IIa trial 59 tesmilifene 59 Complete Response 59 Biologics License Application BLA 59 Phase IIb clinical 59 alogliptin 59 MOZOBIL 59 FavId 59 maribavir 59 clinical trials 59 HGS ETR1 59 valopicitabine 59 Phase 2a clinical 58 ATryn R 58 Phase IIb trial 58 OFIRMEV 58 Phase 1b 58 Phase III clinical 58 ridaforolimus 58 phase 2a 58 Phenoptin 58 IIa clinical trial 58 Biologics License Application 58 clinical trial 58 Neuradiab 58 Marketing Authorization Application 58 Topical Interferon Alpha 2b 57 pivotal Phase III 57 TELCYTA 57 Phase IIa clinical 57 vilazodone 57 Phase 1a 57 DSMB 57 vernakalant oral 57 Phase IIb 57 Phase III 57 Acetavance 57 NDA submission 57 Amigal 57 DR Cysteamine 57 BENLYSTA 57 Rhucin ® 57 LymphoStat B 57 SinuNase 57 Phase Ib 57 Phase III trials 56 thymalfasin 56 RHUCIN 56 refractory Hodgkin lymphoma 56 Phase III clinical trials 56 HERmark 56 Phase 1b clinical 56 PS# [001] 56 dimebon 56 Phase Ia 56 darapladib 56 Marketing Authorization Application MAA 56 OLEPTRO TM 56 tezampanel 56 MAXY G# 56 darusentan 56 PROMACTA 56 INCB# [002] 56 tolerated dose MTD 56 Phase II 55 FOLOTYN 55 denufosol 55 pharmacokinetic studies 55 Icatibant 55 unblinded 55 teduglutide 55 ocrelizumab 55 aflibercept 55 dose escalation 55 Investigational Device Exemption IDE